Reaffirmation - HL7 EHR-System Pharmacist/Pharmacy Provider Functional Profile, Release 1 - US Realm

1a. Project Name Reaffirmation - HL7 EHR-System Pharmacist/Pharmacy Provider Functional Profile, Release 1 - US Realm 1b. Project ID 1723 1c. Is Your Project an Investigative Project (aka PSS-Lite)? No 1d. Is your Project Artifact being Reaffirmed or proceeding to Normative directly after being either Informative or STU? Yes 1e. Today's Date Jul 22, 2021 1f. Name of standard being reaffirmed HL7 EHR-System Pharmacist/Pharmacy Provider Functional Profile, Release 1 - US Realm 1g. Project Artifact Information A project artifact is balloting Normative (no STU) (this includes reaffirmations) 1h. ISO/IEC Standard to Adopt None 1i. Does the standard include excerpted text from one or more ISO, IEC or ISO/IEC standards, but is not an identical or modified adoption? No 1j. Unit of Measure N/A (no measurements are in the standard 2a. Primary/Sponsor WG Electronic Health Record 2d. Project Facilitator Gary Dickinson 2e. Other Interested Parties (and roles) EHR WG Co-Chairs, Co-Facilitators 2f. Modeling Facilitator 2g. Publishing Facilitator 2h. Vocabulary Facilitator 2i. Domain Expert Representative 2j. Business Requirements Analyst 2k. Conformance Facilitator 2l. Other Facilitators 2m. Implementers 3a. Project Scope The Pharmacist/Pharmacy Provider Functional Profile facilitates EHR systems capture of medication and clinical related data at the point of contact or point of care by specifying the functional requirements needed to support messaging among prescribers, pharmacist and pharmacy providers and other health care entities needing medication-related information. Attachments 3b. Project Need Re-affirmation of existing Standard. 3c. Security Risk No 3d. External Drivers 3e. Objectives/Deliverables and Target Dates Re-affirmation ballot, January 2022 ballot cycle 3f. Common Names / Keywords / Aliases: Pharmacy Pharmacist Functional Profile Rx 3g. Lineage 3h. Project Dependencies 3i. HL7-Managed Project Document Repository URL: N/A 3j. Backwards Compatibility No 3k. Additional Backwards Compatibility Information (if applicable) 3l. Using Current V3 Data Types? No 3l. Reason for not using current V3 data types? Not applicable 3m. External Vocabularies No 3n. List of Vocabularies 3o. Earliest prior release and/or version to which the compatibility applies 4a. Products Electronic Health Record (EHR) Functional Profile 4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to? 4c. FHIR Profiles Version 4d. Please define your New Product Definition 4d. Please define your New Product Family 5a. Project Intent Reaffirmation of a standard 5a. White Paper Type 5a. Is the project adopting/endorsing an externally developed IG? 5a. Externally developed IG is to be (select one) 5a. Specify external organization 5a. Revising Current Standard Info 5b. Project Ballot Type Normative (no STU) 5c. Additional Ballot Info 5d. Joint Copyright No 5e. I understand I must submit a Joint Copyright Letter of Agreement to the TSC in order for the PSS to receive TSC approval. no 6a. External Project Collaboration National Council for Prescription Drug Programs (NCPDP) 6b. Content Already Developed ALL 6c. Content externally developed? No 6d. List Developers of Externally Developed Content 6e. Is this a hosted (externally funded) project? No 6f. Stakeholders 6f. Other Stakeholders 6g. Vendors Pharmaceutical, EHR, PHR, Other 6g. Other Vendors Pharmacy System Vendors 6h. Providers Healthcare Institutions (hospitals, long term care, home care, mental health), Other 6h. Other Providers Hospital and Retail Pharmacies 6i. Realm U.S. Realm Specific 7d. US Realm Approval Date 7a. Management Group(s) to Review PSS 7b. Sponsoring WG Approval Date Jul 27, 2021 7c. Co-Sponsor Approval Date 7c. Co-Sponsor 2 Approval Date 7c. Co-Sponsor 3 Approval Date 7c. Co-Sponsor 4 Approval Date 7c. Co-Sponsor 5 Approval Date 7c. Co-Sponsor 6 Approval Date 7c. Co-Sponsor 7 Approval Date 7c. Co-Sponsor 8 Approval Date 7c. Co-Sponsor 9 Approval Date 7c. Co-Sponsor 10 Approval Date 7e. CDA MG Approval Date 7f. FMG Approval Date 7g. V2 MG Approval Date 7h. Architecture Review Board Approval Date 7i. Steering Division Approval Date 7j. TSC Approval Date